ADVFN Logo ADVFN
시장 데이터
뉴스
도구
시장
팔로우

Hot Features

피드 팔로우

Follow Feed 커뮤니티에서 거래자 및 투자자와 연결하세요.

실시간 옵션 플로우

포괄적인 옵션 데이터를 탐색하고 옵션 흐름으로 고급 필터를 사용하세요.

모니터

터미널 모니터로 주식 및 자산 관심 목록을 구성하고 모니터링하세요.
로그인 Premium Icon프리미엄 Help Menu
S&P 500
5,303.27
0.12%
US Tech 100
18,062.00
-0.10%
다우존스 지수
40,003.59
0.34%
Bitcoin
66,787.39
-0.44%
Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.
등록
  1. 홈
  2. 인베스팅
  3. 주식
  4. 미국
  5. NASDAQ
  6. Chemgenex Pharmaceuticals Ltd (MM) (CXSP)

  7. Chemgenex Pharmaceuticals Ltd (MM) (CXSP) 뉴스

CXSP

Chemgenex (CXSP)

Chemgenex Pharmaceuticals Ltd (MM)
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:CXSP
일자시간출처헤드라인심볼기업
2009/06/2922:19Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2009/06/0201:00Business WirePivotal Study Results: ChemGenex’s Omacetaxine May Provide the First Viable Drug Treatment Option for Patients With a Highl...NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2009/05/2219:17Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2009/05/2120:00Business WireChemGenex’s Omacetaxine to be Showcased in Three Oral Presentations at EHANASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2009/05/1904:07Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2009/05/1508:30Business WireChemGenex to Present Pivotal Data in T315I Positive CML Patients as Oral Presentation at ASCONASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2009/05/0423:54Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2009/04/0919:00Business WireChemGenex Completes Capital Raising, Announces Rights IssueNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2009/03/3120:09Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2009/03/2619:40Business WireNew Data Suggesting that ChemGenex’s Omacetaxine Can Eradicate Leukemic Stem Cells May Offer a Breakthrough in Treating CMLNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2009/01/2102:10Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2009/01/1600:45Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2008/12/3104:00Edgar (US Regulatory)Annual and Transition Report (foreign private issuer) (20-F)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2008/12/1001:28Edgar (US Regulatory)Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2008/06/1704:04Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2008/04/0123:59Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2008/04/0121:00Business WireChemGenex Investigators Present Data on Clinical Activity of Omacetaxine in Imatinib-Resistant Chronic Myeloid Leukemia PatientsNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2008/03/0102:41Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2008/01/0721:41Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2008/01/0400:55Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2007/11/2807:25Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Annual and Transition Report (foreign private issuer) (20-F)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2007/10/3101:02Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2007/10/3101:02Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd - Report of Foreign Issuer (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2007/10/0123:41Edgar (US Regulatory)Chemgenex Pharmaceuticals Ltd (Other) (6-K)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2007/06/1205:30Business WireChemGenex Announces Publication Confirming Activity of Ceflatonin(R) in T315I-Positive CMLNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2007/04/0311:27Business WireChemGenex Announces the Completion of A$21 Million FinancingNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2007/01/0602:08Business WireChemGenex Pharmaceuticals: Announcement Pursuant To Nasdaq Marketplace Rule 4350(b)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2006/04/0421:00PR Newswire (US)Preclinical Progress Reported at American Association of Cancer Research ConferenceNASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
2006/03/2308:26PR Newswire (US)New Preclinical Research Supports Ceflatonin(R) in Treatment of Acute Myeloid Leukemia (AML)NASDAQ:CXSP
2006/03/2013:40PR Newswire (US)Orphan Drug Designation Granted by the U.S. FDA for Ceflatonin(R)NASDAQ:CXSPChemgenex Pharmaceuticals Ltd (MM)
 검색 관련기사 보기:NASDAQ:CXSP

최근 히스토리

UPBT
BURSTBTC
Burst
COIN
SACOIUSD
SANUSCOIN
OKEX
LMCHUSDT
EU
ITE
Itesoft
EU
TDT
VanEck ETFs NV
BOV
BHEF39
BlackRock Institutional ...
AMEX
KALL
Kraneshares Msci All Chi...
NASDAQ
ZURA
Zura Bio
GATE
SNETUSDT
Snetwork
COIN
XCNNETH
ASX
BTH
Bigtincan
AMEX
PSCW
Pacer Swan SOS Conservat...
EU
A001Y
Hsbc null
BITMOT
844835
Romania Tf 2,875% Mz29 Eur
EU
Y149S
Y149S
AQSE
GUN
Gunsynd
Delayed Upgrade Clock
ADVFN Logo

대한민국
회사 소개
사업
Popular
앱 받기

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

© 2024 ADVFN PLC - 모든 권리 보유